( I love it when technology products wo...)Presto! A 94-year-old woman goes online
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Presto! A 94-year-old woman goes online
I love it when technology products work as advertised, especially when the product is aimed at the non-technical consumer and I'm the one who has to install and support it. The whole experience is even better when you can surprise and delight someone who thinks most consumer technology has passed her by.
Such was the case this past weekend, when I installed ......
Full article >>>
'"/>
Source:wistechnology.com By Chris Shipley 11/27/06
Related biology technology :
1. WTN Interview with Congresswoman Tammy Baldwin: Facilitating technology growth and regional economic development is a priority
2. Congresswoman Baldwin secures Federal Funds for UW-Rock County
3. Protecting your business against online brand abuse
4. Virtual communities make online connections
5. Mortgagebot builds online sales even as housing declines
6. Lights, cameras, action: The state of online video
7. Google to place Wisconsin history online
8. Location, location, location: Spots to consider for online ads
9. Voice-changing software could make you a troll online
10. Physicians Plus to make alternative drug info available online
11. Wisconsin DFI makes company filings available online
Post Your Comments:
Breaking Biology Technology:Rosalie Dunn, Ph.D., Joins Gwathmey, Inc. as Chief Executive Officer 2Microban Signs Exclusive Agreement with Sharp Electronics to Launch Calculators with New Microban(R) 3G Silver(TM) Antimicrobial Technology 2Successful Stem Cell Therapy for Treatment of Eye Disease 2Successful Stem Cell Therapy for Treatment of Eye Disease 3Successful Stem Cell Therapy for Treatment of Eye Disease 4Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 2Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 3
[0] Rosalie Dunn, Ph.D., Joins Gwathmey, Inc. as Chief Executive Officer[0] Microban Signs Exclusive Agreement with Sharp Electronics to Launch Calculators with New Microban(R) 3G Silver(TM) Antimicrobial Technology[0] Successful Stem Cell Therapy for Treatment of Eye Disease[0] Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products
Other Biology Technology:Ranexa(R) Added to New ACC/AHA Guidelines on Unstable Angina/Non ST-Elevation Myocardial Infarction (UA/NSTEMI) 2Expiry of Hart-Scott-Rodino Waiting Period for JUVISTA(R) (Human TGF BETA 3) 2Expiry of Hart-Scott-Rodino Waiting Period for JUVISTA(R) (Human TGF BETA 3) 3Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML 2Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML 3Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML 4
Ranexa(R) Added to New ACC/AHA Guidelines on Unstable Angina/Non ST-Elevation Myocardial Infarction (UA/NSTEMI)Expiry of Hart-Scott-Rodino Waiting Period for JUVISTA(R) (Human TGF BETA 3)Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
Breaking Biology News(10 mins):Introns: A mystery renewed 2Introns: A mystery renewed 3Introns: A mystery renewed 4 Killer catfish? Venomous species surprisingly common, study finds 2Climate projections underestimate CO2 impact 2New Generation Biofuels Receives NASDAQ Notice of Noncompliance with Continued Listing Requirements 13732 1New Generation Biofuels Receives NASDAQ Notice of Noncompliance with Continued Listing Requirements 13732 2Study Details Swine Flu Transmission Rates 55637 1Study Details Swine Flu Transmission Rates 55637 2Study Details Swine Flu Transmission Rates 55637 3New tool to predict the risk of death in COPD may help physicians to individualize treatment 55633 1New tool to predict the risk of death in COPD may help physicians to individualize treatment 55633 2
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |